From SourceWatch
Jump to navigation Jump to search

Byetta is an in injectable drug (exenatide) for the treatment of type 2 diabetes which is marketed by Amylin Pharmaceuticals and Eli Lilly. The drug was approved for use by the U.S. Food and Drug Administration for use in April 2005. [1]

Company Website


Other SourceWatch Resources

External links

This article is a stub. You can help by expanding it.